B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement.
暂无分享,去创建一个
Mark J. Miller | M. Miller | J. Hodgin | A. Shaw | S. Akilesh | J. Miner | T. Stappenbeck | A. Koziell | Jun-Jae Chung | A. Kim | S. Jain
[1] J. Craig,et al. Corticosteroid therapy for nephrotic syndrome in children. , 2020, The Cochrane database of systematic reviews.
[2] T. Werner,et al. Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice. , 2017, Kidney international.
[3] A. Rudensky,et al. Hallmarks of Tissue-Resident Lymphocytes , 2016, Cell.
[4] Ping Shen,et al. Antibody-independent functions of B cells: a focus on cytokines , 2015, Nature Reviews Immunology.
[5] J. Craig,et al. Corticosteroid therapy for nephrotic syndrome in children. , 2015, The Cochrane database of systematic reviews.
[6] R. Mori,et al. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial , 2014, The Lancet.
[7] M. Sarwal,et al. A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation , 2014, Science Translational Medicine.
[8] B. Basu. Ofatumumab for rituximab-resistant nephrotic syndrome. , 2014, The New England journal of medicine.
[9] Amit Bar-Or,et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases , 2014, Nature.
[10] Hani Suleiman,et al. Rac1 Activation in Podocytes Induces Rapid Foot Process Effacement and Proteinuria , 2013, Molecular and Cellular Biology.
[11] D. Liggitt,et al. Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells , 2013, Nature Immunology.
[12] A. Sinha,et al. Rituximab therapy in nephrotic syndrome: implications for patients' management , 2013, Nature Reviews Nephrology.
[13] M. Hickey,et al. Multiphoton imaging reveals a new leukocyte recruitment paradigm in the glomerulus , 2012, Nature Medicine.
[14] J. Kremer,et al. Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis. , 2012, The New England journal of medicine.
[15] H. Lim,et al. The Clinical Characteristics of Steroid Responsive Nephrotic Syndrome of Children according to the Serum Immunoglobulin E Levels and Cytokines , 2012, Yonsei medical journal.
[16] D. Rawlings,et al. Integration of B cell responses through Toll-like receptors and antigen receptors , 2012, Nature Reviews Immunology.
[17] P. Low,et al. Characterization of in vivo disulfide-reduction mediated drug release in mouse kidneys. , 2012, Molecular pharmaceutics.
[18] C. Antignac,et al. Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. , 2011, The Journal of clinical investigation.
[19] Simon C Watkins,et al. Multiphoton Intravital Microscopy of the Transplanted Mouse Kidney , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[20] E. Salido,et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis , 2011, Nature Medicine.
[21] M. Rastaldi,et al. Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis , 2011, Science Translational Medicine.
[22] A. Chan. B cell immunotherapy in autoimmunity--2010 update. , 2011, Molecular immunology.
[23] P. Nelson,et al. TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α , 2010, Laboratory Investigation.
[24] V. Savin,et al. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[25] S. Kersten,et al. Podocyte secreted Angiopoietin-like 4 mediates proteinuria in glucocorticoid sensitive nephrotic syndrome , 2010, Nature Medicine.
[26] J. Monroe,et al. B‐cell targeted therapies in human autoimmune diseases: an updated perspective , 2010, Immunological reviews.
[27] B. Cheson. Ofatumumab, a novel anti-CD20 monoclonal antibody for the treatment of B-cell malignancies. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] P. Mundel,et al. Proteinuria: an enzymatic disease of the podocyte? , 2010, Kidney international.
[29] S. Kawakami,et al. piggyBac Transposon-mediated Long-term Gene Expression in Mice , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[30] Matthew H. Wilson,et al. PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[31] Richard J. Johnson,et al. Idiopathic nephrotic syndrome and atopy: is there a common link? , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[32] Y. Tomino,et al. T cell cytokine polarity as a determinant of immunoglobulin A (IgA) glycosylation and the severity of experimental IgA nephropathy , 2008, Clinical and experimental immunology.
[33] Emil R. Unanue,et al. Podocytes use FcRn to clear IgG from the glomerular basement membrane , 2008, Proceedings of the National Academy of Sciences.
[34] P. Tan,et al. Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. , 2007, Journal of the American Society of Nephrology : JASN.
[35] I. Gibson,et al. Effect of Palifermin in a Murine Model of Graft-Versus-Host Disease (GVHD) Associated with Th2 Cytokine Production, Autoantibody Production, and Glomerulonephritis , 2006, Journal of Clinical Immunology.
[36] P. Parren,et al. The Biological Activity of Human CD20 Monoclonal Antibodies Is Linked to Unique Epitopes on CD201 , 2006, The Journal of Immunology.
[37] A. Chan,et al. B cell immunobiology in disease: evolving concepts from the clinic. , 2006, Annual review of immunology.
[38] M. Segal,et al. A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome , 2006, Pediatric Nephrology.
[39] F. Dammacco,et al. Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor. , 2006, Blood.
[40] F. Lund,et al. Cutting Edge: The Development of IL-4-Producing B Cells (B Effector 2 Cells) Is Controlled by IL-4, IL-4 Receptor α, and Th2 Cells1 , 2005, The Journal of Immunology.
[41] Min Han,et al. Efficient Transposition of the piggyBac (PB) Transposon in Mammalian Cells and Mice , 2005, Cell.
[42] John W. Evans,et al. Interleukin-4 Produces a Breakdown of Tolerance in vivo with Autoantibody Formation and Tissue Damage , 2004, Autoimmunity.
[43] L. Holzman,et al. Protocadherin FAT1 binds Ena/VASP proteins and is necessary for actin dynamics and cell polarization , 2004, The EMBO journal.
[44] R. Wattiaux,et al. Hydrodynamics-based transfection of the liver: entrance into hepatocytes of DNA that causes expression takes place very early after injection. , 2004, The journal of gene medicine.
[45] M. Duddy,et al. Distinct Profiles of Human B Cell Effector Cytokines: A Role in Immune Regulation?1 , 2004, The Journal of Immunology.
[46] P. Mathieson. Immune dysregulation in minimal change nephropathy. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[47] Kuender D Yang,et al. Implications of serum TNF-beta and IL-13 in the treatment response of childhood nephrotic syndrome. , 2003, Cytokine.
[48] Michael D. Cahalan,et al. Two-photon tissue imaging: seeing the immune system in a fresh light , 2002, Nature Reviews Immunology.
[49] David Gray,et al. B cells regulate autoimmunity by provision of IL-10 , 2002, Nature Immunology.
[50] C. Borrebaeck,et al. Germinal Center B Cells Constitute a Predominant Physiological Source of IL-4: Implication for Th2 Development In Vivo1 , 2002, The Journal of Immunology.
[51] K. HayGlass,et al. Murine graft‐versus‐host disease induced using interferon‐γ‐deficient grafts features antibodies to double‐stranded DNA, T helper 2‐type cytokines and hypereosinophilia , 2002, Immunology.
[52] K. Yamagata,et al. Th2 predominance at the single-cell level in patients with IgA nephropathy. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[53] W. Pearce,et al. Macrophages Transfected with Adenovirus to Express IL-4 Reduce Inflammation in Experimental Glomerulonephritis1 , 2001, The Journal of Immunology.
[54] S. Swain,et al. Reciprocal regulation of polarized cytokine production by effector B and T cells , 2000, Nature Immunology.
[55] P. Davis,et al. Interleukin‐4 transgenic mice develop glomerulosclerosis independent of immunoglobulin deposition , 2000, European journal of immunology.
[56] J. G. van den Berg,et al. Interleukin-4 and interleukin-13 act on glomerular visceral epithelial cells. , 2000, Journal of the American Society of Nephrology : JASN.
[57] P. Davis,et al. Progression of renal disease in interleukin‐4 transgenic mice: involvement of transforming growth factor‐β , 1999, International journal of experimental pathology.
[58] C. Pusey,et al. Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats. , 1999, Kidney international.
[59] S. Jordan,et al. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. , 1999, Journal of the American Society of Nephrology : JASN.
[60] J. Gribben,et al. Human Non-Germinal Center B Cell Interleukin (IL)-12 Production Is Primarily Regulated by T Cell Signals CD40 Ligand, Interferon γ, and IL-10: Role of B Cells in the Maintenance of T Cell Responses , 1999, The Journal of experimental medicine.
[61] C. Meyers,et al. The nephritogenic T cell response in murine chronic graft-versus-host disease. , 1998, Journal of immunology.
[62] A. Hall,et al. Rho GTPases and the actin cytoskeleton. , 1998, Science.
[63] M. Shlomchik,et al. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. , 1998, Journal of immunology.
[64] R. Zeller,et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. , 1997, Experimental cell research.
[65] T. Kurata,et al. Interleukin-4 production in Epstein-Barr virus-transformed B cell lines from peripheral mononuclear cells of patients with atopic dermatitis. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[66] P. Tipping,et al. Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice. , 1997, Kidney international.
[67] V. Pistoia,et al. Production of cytokines by human B cells in health and disease. , 1997, Immunology today.
[68] J. Tobin,et al. Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. , 1997, Journal of the American Society of Nephrology : JASN.
[69] J. Moslehi,et al. Roles of interferon-gamma and interleukin-4 in murine lupus. , 1997, The Journal of clinical investigation.
[70] P. Tipping,et al. Immune modulation with interleukin‐4 and interleukin‐10 prevents crescent formation and glomerular injury in experimental glomerulonephritis , 1997, European journal of immunology.
[71] B. Ryffel,et al. Constitutive Expression of Interleukin (IL)-4 In Vivo Causes Autoimmune-type Disorders in Mice , 1997, The Journal of experimental medicine.
[72] S. Swan,et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. , 1996, The New England journal of medicine.
[73] V. Kindler,et al. Interleukin‐2 secretion by human B lymphocytes occurs as a late event and requires additional stimulation after CD40 cross‐linking , 1995, European journal of immunology.
[74] C. Adida,et al. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon. , 1994, Experimental nephrology.
[75] L. Gesualdo,et al. Profiles of immunoregulatory cytokine production in vitro in patients with IgA nephropathy and their kindred , 1994, Clinical and experimental immunology.
[76] K. Lai,et al. Increase of both circulating Th1 and Th2 T lymphocyte subsets in IgA nephropathy , 1994, Clinical and experimental immunology.
[77] P. Chinn,et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. , 1994, Blood.
[78] P. Niaudet,et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome , 1994, Pediatric Nephrology.
[79] Anne J. Ridley,et al. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling , 1992, Cell.
[80] D. Mason,et al. Development and follicular localization of tolerant B lymphocytes in lysozyme/anti-lysozyme IgM/IgD transgenic mice. , 1992, International immunology.
[81] K. Rajewsky,et al. Generation and analysis of interleukin-4 deficient mice. , 1991, Science.
[82] Klaus Rajewsky,et al. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene , 1991, Nature.
[83] H. Rugo,et al. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. , 1990, International immunology.
[84] R. Poljak,et al. Crystallization and preliminary x-ray diffraction studies of two new antigen-antibody (lysozyme-Fab) complexes. , 1988, Journal of molecular biology.
[85] S. Smith‐Gill,et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice , 1988, Nature.
[86] W. Paul,et al. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1 , 1985, Nature.
[87] R. Shalhoub. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. , 1974, Lancet.
[88] C. Rozo,et al. The Role of B Cells in the Development of CD4 Effector T Cells during a Polarized Th2 Immune Response , 2007 .
[89] H. Schnaper,et al. Nephrotic syndrome: minimal change nephropathy, focal segmental glomerulosclerosis and collapsing glomerulopathy , 2006 .
[90] Michael D. Abràmoff,et al. Image processing with ImageJ , 2004 .
[91] W. Paul,et al. The IL-4 receptor: signaling mechanisms and biologic functions. , 1999, Annual review of immunology.
[92] P. Tipping,et al. Interleukin-4 deficiency enhances Th1 responses and crescentic glomerulonephritis in mice. , 1998, Kidney international.
[93] M. T. Gordon,et al. Intrarenal cytokine mRNA expression and location in normal and IgA nephropathy tissue: TGF alpha, TGF beta, IGF 1, IL-4 and IL-6. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[94] M. T. Gordon,et al. Intrarenal cytokine mRNA expression and location in normal and IgA nephropathy tissue: TGFα, TGFβ, IGF 1, IL-4 and IL-6 , 1994 .
[95] E.E. Pissaloux,et al. Image Processing , 1994, Proceedings. Second Euromicro Workshop on Parallel and Distributed Processing.